Gedatolisib, sold under the brand name Revtorpyk, is an anti-cancer medication used for the treatment of breast cancer. Gedatolisib is a kinase inhibitor. The mechanism of action is accomplished by binding the different p110 catalytic subunit isoforms of PI3K and the kinase site of mTOR.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.